Announcement • May 21
Hopium SA, Annual General Meeting, Jun 29, 2026 Hopium SA, Annual General Meeting, Jun 29, 2026. Location: 38 rue laffitte, paris France New Risk • Nov 15
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (51% average weekly change). Negative equity (-€36m). Earnings have declined by 15% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 34x increase in shares outstanding). Revenue is less than US$1m (€21k revenue, or US$24k). Market cap is less than US$10m (€1.58m market cap, or US$1.84m). Minor Risk Latest financial reports are more than 6 months old (reported December 2024 fiscal period end). Announcement • May 22
Hopium SA, Annual General Meeting, Jun 06, 2025 Hopium SA, Annual General Meeting, Jun 06, 2025. Location: u 30 rue du chateau des rentiers, paris France Reported Earnings • May 05
Full year 2024 earnings released Full year 2024 results: Net loss: €10.5m (loss narrowed 66% from FY 2023). New Risk • Sep 16
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€9.2m free cash flow). Share price has been highly volatile over the past 3 months (21% average weekly change). Negative equity (-€36m). Revenue has declined by 100% over the past year. Shareholders have been substantially diluted in the past year (over 17x increase in shares outstanding). Revenue is less than US$1m (€13k revenue, or US$14k). Market cap is less than US$10m (€5.48m market cap, or US$6.08m). Minor Risk Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Announcement • May 26
Hopium SA, Annual General Meeting, Jun 27, 2024 Hopium SA, Annual General Meeting, Jun 27, 2024. Location: 7 rue auber, paris France Reported Earnings • Apr 24
Full year 2023 earnings released Full year 2023 results: Net loss: €30.7m (loss widened 28% from FY 2022). New Risk • Jan 25
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 118% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Negative equity (-€32m). Revenue has declined by 30% over the past year. Shareholders have been substantially diluted in the past year (118% increase in shares outstanding). Market cap is less than US$10m (€1.96m market cap, or US$2.14m). Minor Risk Revenue is less than US$5m (€2.0m revenue, or US$2.2m). New Risk • Nov 10
New major risk - Revenue and earnings growth Revenue has declined by 30% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Negative equity (-€32m). Revenue has declined by 30% over the past year. Market cap is less than US$10m (€1.95m market cap, or US$2.08m). Minor Risks Shareholders have been diluted in the past year (46% increase in shares outstanding). Revenue is less than US$5m (€2.0m revenue, or US$2.1m). New Risk • Jul 31
New major risk - Market cap size The company's market capitalization is less than US$100m. Market cap: €9.08m (US$10.0m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Negative equity (-€10m). Minor Risks Shareholders have been diluted in the past year (11% increase in shares outstanding). Revenue is less than US$5m (€4.0m revenue, or US$4.4m). Market cap is less than US$100m (€9.08m market cap, or US$10.0m). Announcement • Dec 01
Hopium Société anonyme (ENXTPA:MLHPI) acquired Young Innovative Company. Hopium Société anonyme (ENXTPA:MLHPI) acquired Young Innovative Company on November 30, 2021.
Hopium Société anonyme (ENXTPA:MLHPI) completed the acquisition of Young Innovative Company on November 30, 2021. Announcement • Jun 18
Hopium Unveils Its Hydrogen-powered Sedan Prototype And Opens The First 1000 Pre-orders Hopium unveiled its very first rolling prototype during the Viva Technology week in Paris. Announced in October 2020 and produced in record time in the Linas-Montlhéry test workshop, this vehicle called Alpha 0, certifies the reliability of the fuel cell system. After the design and architecture phases, followed by the implementation of the various components within the vehicle, the prototype was able to be evaluated and perfected through bench and track tests. With a speed of 200 km/h (124 mph), this test version already borders on the performance promised by the Hopium Machina in its final form. Alpha 0 also introduces for the first time the signature lighting, emblem of Hopium, whose shape is reminiscent of the stratification of hydrogen and the movement of waves on the surface of water. The reveal of this technological showcase is a key step in the manufacturer's roadmap and confirms its ability to achieve the goals that have been set and meet the high challenges. It is accompanied by the opening of an order book for the first 1,000 numbered units of Hopium Machina, whose reservation price is set at 410 euros, in reference to the spectral line of hydrogen. The Hopium teams are already fully committed in carrying out the next steps, aiming to produce Hopium Machina on an industrial scale, with a new rendez-vous expected in the first quarter of 2022. 